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The key roles played by phospholipids in many cellular processes, has led to the development of model
systems, to explore both lipid–lipid and lipid–peptide interactions. Biomimetic giant unilamellar vesicles
represent close facsimiles of in vivo cellular membranes, although currently their widespread use in
research is hindered by difficulties involving their integration into high-throughput techniques, for explor-
ing membrane biology intensively in situ. This paper presents an integrated microfluidic device for the
production, manipulation and high-throughput analysis of giant unilamellar vesicles. Its utility is demon-
strated by exploring the lipid interaction dynamics of the pore-forming antimicrobial peptide melittin,
assessed through the release of fluorescent dyes from within biomimetic vesicles, with membrane com-
positions similar to mammalian plasma membranes.Introduction
Membrane research has undergone a significant shift in
focus, and membranes are now recognised as active media-
tors of several key cellular processes, including membrane
signal transduction;1,2 membrane-protein structure and func-
tion3,4 and vesicle trafficking.5,6 Indeed the diverse biological
functions assigned to lipids have led to a recent increase of
interest in membrane biology, although experimental analy-
sis of lipid–lipid and lipid–peptide interactions remains chal-
lenging.7,8 Currently several different lipidic platforms are
available for investigation of membrane interactions, includ-
ing small, large and giant unilamellar vesicles (SUV, LUV,
and GUVs respectively) as well as supported lipid bilayers
(SLBs).9–11 GUVs are one of the most popular platforms for
studying lipid–lipid and lipid–protein interactions,12–14 offer-
ing high biological relevance and convenience of use. They
are of similar size (10–20 μm) and membrane curvatures to
typically studied mammalian cells like erythrocytes, and are
composed of single unsupported lipid bilayers.11,15 Moreover,
GUV lipid composition can be pre-defined to build close fac-
similes of in vivo cellular membranes, creating biomimetic
vesicles. Their size allows for the use of conventional fluores-
cent microscopy techniques, enabling lipid–lipid and lipid–
protein interactions to be readily visualised.Conventional GUV experiments require each vesicle to be
individually addressed within the experimental system, typi-
cally using micromanipulated micropipettes. These methods
are known collectively as “single GUV techniques”, and have
recently been used to investigate the lipid–peptide interac-
tions occurring during cellular apoptosis16 and pore-
formation by antimicrobial peptides.17,18 However these tech-
niques suffer from specific experimental limitations, in that
they are intrinsically low-throughput (collecting data from
one GUV at a time), and allow only limited control over mem-
brane exposure to substances. In this paper, we build upon
established microfluidic technologies to develop a novel plat-
form combining high-throughput fluorescence microscopy
analysis with precise control over membrane exposure to sol-
utes. Importantly, this platform allows on-chip production of
GUVs, together with their manipulation and analysis at high-
throughput, providing the potential to widen the accessibility
of GUVs as membrane models for the study of lipid–lipid
and lipid–protein interactions. In contrast to existing single
GUV techniques, the new method does not require that the
operator has technical expertise in GUV handling. On-chip
electroformation was used to create mammalian biomimetic
vesicles (mGUVs) with a membrane composition representa-
tive of typical mammalian membranes, enclosing fluores-
cently tagged dextrans. The mGUVs are positioned using
laminar flow into trap microarrays, which have previously
been used for single cell analysis19 (Fig. 1). We demonstrate
the efficacy of the proposed platform, by gathering biologi-
cally relevant dye-leakage data, triggered by the membrane
interactions of the pore-forming antimicrobial peptide (AMP)
melittin.20,21oyal Society of Chemistry 2014
Fig. 1 (a) Exploded 3D diagram of the device, showing (1) clamp;
(2) lipid-coated ITO-coated slide; (3) PDMS device and (4) ITO-coated
slide, arranged into a glass-PDMS-glass sandwich. (b) Plan view of chip
design, showing the electroformation and microtrap analysis cham-
bers, connected by microfluidic channels (1), also depicted are the
(2) wash and (3) peptide channels, as well as a collective outlet for
waste (4). Dashed lines on the electroformation chamber were excised
from the PDMS device, in order to carry out the electroformation procedure.
Fig. 2 (a) Confocal image of mGUV cross-section (dextran-AlexaFluor488
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View Article OnlineMaterials and methods
Device microfabrication
The microfluidic device was manufactured as a 2 mm thick
PDMS cast, from a silicon/SU8-3050 master mould, using
standard contact photolithographic techniques. Briefly, an
MA6 contact aligner system (SUSS Microtech Ltd., Coventry,
UK) was used to pattern the inverse device design onto a
50 μm thick layer of SU8-3050, spin-coated onto a silicon
wafer. Non-crosslinked photoresist was removed by develop-
ment in Microposit EC solvent, and the resultant master mould
silanised using 1H,1H,2H,2H-perfluorooctyl-trichlorosilane
(Sigma-Aldrich). PDMS devices were cast and released from
this master mould.excluded from solution, to facilitate domain visualisation). Distinct lipid
domains of liquid-disordered DOPC (1 – red) and liquid-ordered DPPC/
cholesterol (2 – green) are visible. The slight mismatch seen in domain
diameters is due to differences in mechanical properties between
liquid-ordered and -disordered phases. Scale bar represents 5 μm. (b)
SEM image of trap microarray region. Scale bar represents 50 μm.
(c) mGUVs within the microtrap array, visualised using enclosed
dextran-AlexaFluor488. Scale bar represents 50 μm.Electroformation of GUVs
mGUVs were manufactured on-chip using established electro-
formation protocols,22,23 implemented within the micro-
fluidic device (see ESI†). The lipid composition DOPC :
DPPC : cholesterol (35 : 35 : 30 mol%) was selected toThis journal is © The Royal Society of Chemistry 2014represent a typical mammalian membrane, and the mixture
was doped with 0.05 mol% of DPPE-rhodamine lissamine B
and 0.1 mol% cholesterol-BODIPY (DPPE-rhodamine is a
fluid-phase membrane marker, while cholesterol-BODIPY
localises in the gel-phase),24,25 allowing lipid domain visuali-
sation by fluorescent microscopy, Fig. 2.Dye leakage experiment
The sugar density gradient between vesicle interior (sucrose)
and exterior (glucose) solutions, causes vesicles to settle to
the bottom of the electroformation chamber, facilitating visu-
alisation and their loading into the microarray traps. Vesicles
were transferred into the microtrap chamber, by flowing an
iso-osmotic wash solution consisting of 100 mM glucose, 5.0
mM HEPES (pH adjusted to 7.4 using KOH), through the
flow channel (Fig. 1, channel 1). Extraneous dye was removed
from the solution by flowing wash solution through the wash
channel (Fig. 1, channel 2). This resulted in mGUVs withLab Chip, 2014, 14, 1806–1810 | 1807
Fig. 3 Dye-leakage traces recorded from a single experiment, with
each trace representing averaged leakage data from at least 4 vesicles,
and error bars showing the standard deviation; (top) leakage kinetics
for dye-enclosing mGUVs, with an average diameter of 15.97 ± 4.69
μm, exposed to 5 μM melittin. The data show clear grouping of the
leakage kinetics into three distinct modes. (Inset) Series of fluorescent
pictures, showing the escape of 3 kDa dextran-AlexaFluor488, induced
by the AMP melittin. Numbers depict time (s) since onset of leak, and
microarray trap outlined in white, for the first picture in series. Scale
bar represents 10 μm. (Bottom) Data recorded from entrapped mGUVs,
with an average diameter of 19.13 ± 7.61 μm, after exposure to 1 μM
AMP. Data shows the same grouping of the data seen in Fig. 3 (top),
but shifted to slower leakage kinetics, in response to exposure to lower
levels of melittin.
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View Article Onlinered/green stained membranes, enclosing fluorescently tagged
dextran, gently pinned against the PDMS trap pillars by
continuous laminar flow (Fig. 2c). Prior to exposure to AMP,
vesicle unilamellarity was assessed using a Zeiss LDM 5 Live
confocal microscope (Carl Zeiss Ltd., Cambridge, UK). A wash
solution doped with 1.0 or 5.0 μM melittin was then flowed
over the entrapped mGUVs (Fig. 1, channel 3). Fluorescent
data was captured at 0.25 Hz, using the confocal microscope,
with the pinhole set to collect images encompassing the
entire channel height. Data was corrected for photo-
bleaching, and the fluorescence intensity normalised, to aid
comparison between different vesicles.
Results
On-chip electroformation of mGUVs
On-chip vesicles were comparable to those manufactured by
similar off-chip procedures, i.e. similar in size, unilamellar in
nature and displaying lateral lipid heterogeneity.26 The lipid
composition chosen resulted in the formation of distinct
domains, based on preferential lipid aggregation (Fig. 2),
similar to the lipid rafts occurring in vivo;27 DPPC/cholesterol
formed liquid-ordered domains, visualised using BODIPY-
tagged cholesterol (green), and DOPC formed liquid-
disordered domains, visualised using DPPE-rhodamine (red).
On-chip electroformation produced higher purity products
than off-chip, with noticeably reduced amounts of non-
vesicular lipid debris, which can obfuscate experimental anal-
ysis. Vesicle yield was reduced to ca. 56% of that seen in
off-chip procedures, however it should be noted that the
number of GUVs produced was always several orders of mag-
nitude greater than the number of vesicles trapped. A shift in
the size distribution profile of trapped vesicles towards larger
diameters demonstrates the size exclusion (filter) properties
of the device (see ESI†).
Dye-leakage
Conventional dye-leakage experiments require the removal of
extraneous dye, by either repeated dilution28 and/or size-
exclusion chromatography,28,29 reducing GUV yield. By pro-
ducing vesicles on-chip and containing the dye-filled mGUVs
within PDMS microtrap arrays, we were able to exploit the
exquisite control over fluid flow enabled by microfluidics,
allowing manipulations including washing steps and expo-
sure to small aliquots of ligands, to be easily integrated into
experimental protocols. The geometry of the microfluidic
channels and microarray traps act as a size-exclusion filter,
resulting in a more homogeneous GUV size distribution. The
desired size range of vesicles can be selected in the chip
design – in this paper we trapped mGUVs ca. 10–40 μm in
diameter, comparable to typical mammalian cells. As a result,
robust statistical data can be acquired from single experi-
ments, significantly increasing research throughput. Repre-
sentative dye-leakage data is presented in Fig. 3, where
leakage was assessed from entrapped mGUVs, after exposure
to 5 (Fig. 3, top) and 1 (Fig. 3, bottom) μM of melittin.1808 | Lab Chip, 2014, 14, 1806–1810The data showed distinct grouping into three clearly sepa-
rated modes of leakage, which could be seen independently
of the flow rate. The dextrans also displayed faster leakage
kinetics in response to higher levels of the AMP.
Discussion
The lower GUV yield of on-chip electroformation can be
explained by consideration of the fluid flows experienced by
the vesicles during electroformation. Removal of GUVs from
off-chip electroformation chambers involved bulk flow of the
surrounding solution, while on-chip vesicles experienced
reduced flow velocities. This resulted in reduced detachment
of vesicles from the ITO-slide, but also in lower amounts ofThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineunwanted detached non-vesicular lipid debris, producing a
purer electroformation product. The lower yield of on-chip
electroformation is not significant experimentally, as the pro-
cedure produces many orders of magnitude more GUVs than
are analysed. However the reduced lipidic debris provides a
significant increase in preparation quality. Exposure of
mGUVs to AMP induced leakage of fluorescently-tagged dex-
trans across the lipid membrane for both concentrations of
melittin used. The data gathered displayed grouping into dis-
tinct kinetic “modes” of leaking. The exact nature of the dif-
ferent mechanisms of leakage, arising as a function of the
lipid–peptide interactions, will be the subject of further inves-
tigations. It is worthwhile noting that, under the laminar flow
conditions used (Re ~ 0.0003), AMP delivery is diffusion lim-
ited, and as such, exposure to higher concentrations of
melittin produced faster leakage kinetics. Care should be
taken when comparing these results to those obtained using
classical single GUV methods, due to the differing nature of
vesicle exposure to AMP. This method uses continuous expo-
sure to low levels of peptide, whereas most single GUV
methods, feature acute exposures to higher levels of peptide.
Conclusions
Integrated mGUV manufacture, microfluidic manipulation
and analysis within a microfluidic device was demonstrated
by the collection of reproducible, high-throughput dye leak-
age data. The device can easily be adapted for other applica-
tions; e.g. investigation of in vitro protein expression in
microdroplets30 or lipid dynamic studies.27 Integrated micro-
fluidic GUV analysis possesses several inherent advantages
over conventional experimental techniques, including reduc-
ing vesicle strain and precise control over vesicle exposure to
solutes. The method enables washing steps to be easily incor-
porated into experimental protocols. Compared to conven-
tional single GUV techniques, integrated microfluidic analysis
is of significantly higher throughput, enabling large data sets
to be collected efficiently. Other benefits include requiring
less specialised operator training and equipment. Typical
dye-leakage experiments report data from <10 individual
vesicles,31,32 while the application of microfluidic technology
allows the simultaneous gathering of data, from over 80 GUVs
in one experiment (see ESI†). This ca. ten-fold increase in
throughput generates robust data sets, allowing statistical
techniques to be applied to membrane interactions, adding an
important analytical method to the membrane interaction
toolbox. The clearly defined leakage kinetic families indicate
the occurrence of different lipid–AMP interactions within the
membrane, leading to three distinct “modes” of leaking.
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